Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 1, 2008, Pages 224-231

  Troisi, Rebecca ^a,b,j   Lagiou, Pagona ^c,d,f   Trichopoulos, Dimitrios ^d,f   Xu, Biao ^g   Chie, Lucy ^e   Stanczyk, Frank Z ^h   Potischman, Nancy ^a   Adami, Hans Olov ^d,f   Hoover, Robert N ^a   Hsieh, Chung Cheng ^d,f,i  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g FUDAN UNIVERSITY   (China)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^j DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTRIOL; ESTROGEN; PROLACTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STEROID HORMONE; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CAUCASIAN; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTRIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ETHNIC DIFFERENCE; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTERVIEW; LINEAR REGRESSION ANALYSIS; MATERNAL AGE; MATHEMATICAL MODEL; MEDICAL RECORD; NEWBORN; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RACE DIFFERENCE; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; UMBILICAL CORD BLOOD; UNITED STATES; WEIGHT GAIN;

ADULT; ANDROGENS; BIRTH WEIGHT; BREAST NEOPLASMS; CHINA; ESTROGENS; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; PREGNANCY; RISK FACTORS; UNITED STATES;

EID: 38849126084     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0536     Document Type: Article

References (44)

1. CANCERMondial; 2002. Available from: http://www-dep.iarc.fr/.
2. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American Women. J Natl Cancer Inst 1993;85:1819-27.
3. Wu AH, Ziegler RG, Pike MC, et al. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 1996;73:680-6.
4. Ursin G, Wu AH, Hoover RN, et al. Breast cancer and oral contraceptive use in Asian-American women. Am J Epidemiol 1999;150:561-7.
5. Buell P. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 1973;51:1479-83.
6. Miller AB, Bulbrook RD. UICC Multidisciplinary Project on Breast Cancer: the epidemiology, aetiology and prevention of breast cancer. Int J Cancer 1986;37:173-7.
7. Willett WC, MacMahon B. Diet and cancer - an overview. N Engl J Med 1984;310:633-8, 697-703.
8. National Cancer Institute. Summary report: early reproductive events and breast cancer workshop; 2003. Available from: http://cancer.gov/cancerinfo/ ereworkshop-report.
9. Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet 1990;335:939-40.
10. Key TJA, Chen J, Wang DY, Pike MC, Boreham J. Sex hormones in women in rural China and in Britain. Br J Cancer 1990;62:631-6.
11. Bernstein L, Yuan J-M, Ross RK, et al. Serum hormone levels in premenopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control 1990;1:51-8.
12. Falk RT, Fears TR, Hoover RN, et al. Does place of birth influence endogenous hormone levels in Asian-American women. Br J Cancer 2002;87:54-60.
13. Lipworth L, Hsieh C-C, Wide L, et al. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999;79:7-12.
14. Lambe M, Trichopoulos D, Hsieh CC, Wuu J, Adami HO, Wide L. Ethnic differences in breast cancer risk: a possible role for pregnancy levels of alpha-fetoprotein? Epidemiology 2003;14:85-9.
15. Goebelsmann U, Bernstein GS, Gale JA, et al. Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. In: Lepow IH, Crozier R, eds. Vasectomy: immunologic and pathophysiologic effects in animals and man. New York: Academic Press; 1979. p. 165.
16. Goebelsmann U, Arce JJ, Thorneycroft IH, Mishell DR, Jr. Serum testosterone concentrations in women throughout the menstrual cycle and following hCG administration. Am J Obstet Gynecol 1974;119:445-52.
17. Goebelsmann U, Horton R, Mestman JH, et al. Male pseudohermaphroditism due to testicular 17-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1973;36:867.
18. Katagiri H, Stanczyk FZ, Goebelsmann U. Estriol in pregnancy. III. Development, comparison and use of specific antisera for rapid radioimmunoassay of unconjugated estriol in pregnancy plasma. Steroids 1974;24:225-38.
19. Armitage P, Berry G. Statistical methods in medical research. Boston: Blackwell Boston; 1987.
20. Yeung LPK, Wong ACK, Wang X, Birmingham CL, Lewicka S, Chanoine J-P. Different relationship between anthropometric markers and umbilical cord plasma leptin in Asian and Caucasian neonates. Pediatric Res 2003;53:1019-24.
21. Shibata A, Harris DT, Billings PR. Concentrations of estrogens and IGFs in umbilical cord blood plasma: a comparison among Caucasian, Hispanic, and Asian-American females. J Clin Endocrinol Metab 2002;87:810-5.
22. Carr BR. The maternal-fetal-placental unit. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. 2nd ed. Philadelphia: J.B. Lippincott; 1995.
23. Troisi R, Potischman N, Roberts JM, et al. Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev 2003;12:452-6.
24. Lagiou P, Samoli E, Lagiou A, Hsieh CC, Adami HO, Trichopoulos D. Maternal height, pregnancy estriol and birth weight in reference to breast cancer risk in Boston and Shanghai. Int J Cancer 2005;117:494-8.
25. Ekbom A, Hsieh C-C, Lipworth L, Adami H-O, Trichopoulos D. Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 1997;88:71-6.
26. Hsieh C-C, Lan S-J, Ekbom A, Petridou E, Adami H-O, Trichopoulos D. Twin membership and breast cancer risk. Am J Epidemiol 1992;136:1321-6.
27. Weiss HA, Potischman NA, Brinton LA, et al. Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology 1997;8:181-7.
28. Braun MM, Ahlbom A, Floderus B, Brinton L, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast and other sites (Sweden). Cancer Causes Control 1995;6:519-24.
29. Cerhan JR, Kushi LH, Olson JE, et al. Twinship and risk of postmenopausal breast cancer. J Natl Cancer Inst 2000;92:261-5.
30. Verkasalo PK, Kaprio J, Pukkala E, Koskenvuo M. Breast cancer risk in monozygotic and dizygotic female twins: a 20-year population-based cohort study in Finland from 1976 to 1995. Cancer Epidemiol Biomarkers Prev 1999;8:271-4.
31. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999;10:722-32.
32. Mucci LA, Lagiou P, Tamimi RM, Hsieh CC, Adami H-O, Trichopoulos D. Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes Control 2003;14:311-8.
33. Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A. Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology 2000;11:315-9.
34. Troisi R, Potischman N, Neuser Johnson C, et al. Estrogen and androgen concentrations are not lower in the umbilical cord serum of preeclamptic pregnancies. Cancer Epidemiol Biomarkers Prev 2003;12:1268-70.
35. Atamer Y, Erden AC, Demir B, Koçyigit Y, Atamer A. The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women. Acta Obstet Gynecol Scand 2004;83:425-30.
36. Troisi R, Potischman N, Roberts JM, Siiteri P, Hoover RN. Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors. Cancer Causes Control 2003;14:347-55.
37. Nagata C, Iwasa S, Shiraki M, Shimizu H. Estrogen and α-fetoprotein levels in maternal and umbilical cord blood samples in relation to birth weight. Cancer Epidemiol Biomarkers Prev 2006;15:1469-72.
38. Simmons D, France JT, Keelan JA, Song L, Knox BS. Sex differences in umbilical cord serum levels of inhibin, testosterone, oestradiol, dehydroepiandrosterone sulphate, and sex hormone-binding globulin in human term neonates. Biol Neonate 1994;65:287-94.
39. Thomas HV, Murphy MF, Key TJ, Fentiman IS, Allen DS, Kinlen LJ. Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Hum Biol 1998;25:69-75.
40. Troisi R, Potischman N, Roberts JM, et al. Maternal serum hormone concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003;32:455-60.
41. Drews U, Drews U. Regression of mouse mammary gland anlagen in recombinants of Tfm and wild-type tissues: testosterone acts via the mesenchyme. Cell 1977;10:401-4.
42. Wald N, Cuckle H, Wu TS, George L. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Br J Obstet Gynaecol 1991;98:905-8.
43. Yen SSC. Endocrine-metabolic adaptations in pregnancy. In: Yen SSC, Jaffe RB, editors. Reproductive endocrinology. Philadelphia: W.B. Saunders; 1991. p. 936-81.
44. Potischman N, Troisi R. In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control 1999;10:561-73.